MOORESVILLE, N.C., June 19, 2024 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE: LOW) announces that Marvin R. Ellison, chairman and chief executive officer, and Brandon J. Sink, chief financial officer, will participate in a virtual fireside chat hosted by Oppenheimer & Co. Inc. What: Marvin Ellison and Brandon Sink to participate in virtual fireside chat hosted by Brian Nagel from Oppenheimer & Co. Inc. When: 9:00 a.m. ET on Wednesday, June 26, 2024 Where: Visit Lowe's Investor Relations for the video webca ...

Company Overview - Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) for treating chronic mast and stem cell diseases [2][5] - The company aims to address conditions such as chronic urticaria and myelodysplastic syndromes (MDS), as well as serve as a conditioning agent for stem cell transplants in rare diseases like sickle cell disease, Fanconi anemia, and severe combined immunodeficiency [2][5] Clinical Development - Briquilimab has shown efficacy and safety in over 145 participants, including healthy volunteers, with positive clinical outcomes in conditions such as SCID, acute myeloid leukemia, MDS, FA, and SCD [2] - The company will present its findings at the Oppenheimer Novel Targets in Immunology Summit on June 24, 2024, in New York City [5] Market Focus - Jasper Therapeutics is targeting mast cell-driven diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and asthma, indicating a focused approach in the immunology sector [5]

WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at 11:45 AM ET on June 24, 2024 at the Oppenheimer Novel Targets in Immunology Summit in New York, NY. About Avalo Therapeutics Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of ...

TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on Monday, June 10, 2024 at 1:30 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors" section and the "Events and Presentations" tab, or by using the following link: For those unable to participate during the live webcast, a replay optio ...

PHILADELPHIA, PA, June 06, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trendright, high-quality extreme-value retailer for tweens, teens and beyond, today announced that management will participate in Oppenheimer's 24th Annual Consumer Growth and E-Commerce Conference to be held virtually. Management is currently scheduled to participate in a fireside chat on Wednesday, June 12, 2024 at 2:15 p.m. Eastern Time. About Five Below: Investor Contact: Five Below, Inc. Christiane Pelz VP, Investo ...

Company Participation in Conference - Hormel Foods Corporation will participate in the 2024 Oppenheimer Consumer Growth & ECommerce Conference on June 10, 2024, at 11:45 a.m. CT [1] - The company will be represented by Jim Snee, chairman of the board, president and CEO, and Jacinth Smiley, executive vice president and CFO [1] - A live webcast, replay, and related information can be accessed on the company's investor website [2] Company Overview - Hormel Foods Corporation is a Fortune 500 global branded food company with over $12 billion in annual revenue [3] - The company operates in more than 80 countries worldwide and owns over 30 beloved brands, including Planters, SKIPPY, SPAM, and Hormel Natural Choice [3] - Hormel Foods is a member of the S&P 500 Index and the S&P 500 Dividend Aristocrats [3] - The company has received numerous awards and accolades for corporate responsibility, community service, and workplace innovation, including a perfect score of 100 on the 2023–24 Corporate Equality Index [3] Brand and Market Presence - Hormel Foods' brands are recognized globally, with a strong presence in the food industry [3] - The company's purpose statement, "Inspired People Inspired Food," reflects its commitment to delivering trusted and iconic brands worldwide [3]

LEHI, Utah, June 4, 2024 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple") a comfort innovation company known for creating the "World's First No Pressure™ Mattress," today announced that the Company will make a presentation at the Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference. The presentation is scheduled for Monday, June 10, 2024 at 10:30 a.m. Eastern Time. The presentation will be simultaneously broadcast on the internet and available at https://investors.purple.com/. Ab ...

SPARTANBURG, S.C., June 04, 2024 (GLOBE NEWSWIRE) -- Denny's Corporation (the "Company") (NASDAQ: DENN), owner and operator of Denny's Inc. ("Denny's") and Keke's Inc. ("Keke's"), today announced that the Company will participate virtually in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference. The Company will hold investor meetings during the conference, and Kelli Valade, Chief Executive Officer, will present on Monday, June 10, 2024, at 9:45 a.m. Eastern Time. Investors and interested p ...

ANN ARBOR, Mich., June 4, 2024 /PRNewswire/ -- Domino's Pizza, Inc. (NYSE: DPZ) announces the following event: What: Domino's to participate in fireside chat at Oppenheimer's 24th Annual Consumer Growth and ECommerce Conference, featuring Chief Financial Officer, Sandeep Reddy When: Monday, June 10 at 11:15 a.m. ET Where: https://wsw.com/webcast/oppenheimer36/dpz/2574502 How: Live webcast (web address above) This event will be archived on Domino's website for replay. About Domino's Pizza® Founded in 1960, D ...

Highly experienced, London-based banker to lead firm's newly established Healthcare M&A practice NEW YORK, June 4, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin. Based in London, Chamberlin will serve as a Managing Director and Head of European Healthcare. In that role, he will lead ...